Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Naproxen tablet
DRUG
2 trials
Sponsors
Biolab Sanus Farmaceutica
, University of Washington
Conditions
Gastrointestinal Lesions
Pharmacogenetics
Phase 1
Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo
Completed
NCT02632812
Biolab Sanus Farmaceutica
Gastrointestinal Lesions
Start: 2014-10-31
End: 2014-11-30
Updated: 2017-03-20
Phase 4
Naproxen Pharmacogenetic Study (Project 1, Aim 2)
NCT04449471
University of Washington
Pharmacogenetics
Start: 2016-01-12
End: 2022-07-31
Target: 30
Updated: 2020-06-29
Related Papers
Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.
2016-06-04
5 citations